A detailed history of Capital International Investors transactions in Genmab A/S stock. As of the latest transaction made, Capital International Investors holds 4,421,617 shares of GMAB stock, worth $89.8 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
4,421,617
Previous 4,227,965 4.58%
Holding current value
$89.8 Million
Previous $106 Million 1.46%
% of portfolio
0.02%
Previous 0.02%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$23.84 - $28.48 $4.62 Million - $5.52 Million
193,652 Added 4.58%
4,421,617 $108 Million
Q2 2024

Aug 13, 2024

SELL
$25.13 - $30.27 $3.65 Million - $4.4 Million
-145,312 Reduced 3.32%
4,227,965 $106 Million
Q1 2024

May 14, 2024

BUY
$26.43 - $32.77 $8.33 Million - $10.3 Million
315,355 Added 7.77%
4,373,277 $131 Million
Q4 2023

Feb 13, 2024

SELL
$27.94 - $35.44 $7.28 Million - $9.23 Million
-260,420 Reduced 6.03%
4,057,922 $129 Million
Q3 2023

Nov 13, 2023

BUY
$35.27 - $42.24 $4.28 Million - $5.12 Million
121,282 Added 2.89%
4,318,342 $152 Million
Q2 2023

Aug 11, 2023

BUY
$37.4 - $42.94 $3.3 Million - $3.79 Million
88,355 Added 2.15%
4,197,060 $160 Million
Q1 2023

May 15, 2023

BUY
$34.88 - $43.22 $2.16 Million - $2.67 Million
61,869 Added 1.53%
4,108,705 $155 Million
Q4 2022

Feb 14, 2023

SELL
$33.8 - $47.06 $27 Million - $37.6 Million
-799,460 Reduced 16.5%
4,046,836 $172 Million
Q3 2022

Nov 14, 2022

BUY
$31.52 - $373.61 $4.7 Million - $55.7 Million
149,201 Added 3.18%
4,846,296 $155 Million
Q2 2022

Aug 15, 2022

BUY
$26.83 - $38.57 $20 Million - $28.7 Million
744,649 Added 18.84%
4,697,095 $149 Million
Q1 2022

May 16, 2022

BUY
$30.95 - $39.68 $8.76 Million - $11.2 Million
283,031 Added 7.71%
3,952,446 $145 Million
Q4 2021

Feb 14, 2022

SELL
$35.87 - $47.12 $972,794 - $1.28 Million
-27,120 Reduced 0.73%
3,669,415 $146 Million
Q3 2021

Nov 15, 2021

BUY
$41.55 - $48.72 $7.04 Million - $8.25 Million
169,379 Added 4.8%
3,696,535 $157 Million
Q2 2021

Aug 16, 2021

BUY
$32.88 - $44.57 $8.57 Million - $11.6 Million
260,648 Added 7.98%
3,527,156 $146 Million
Q1 2021

May 14, 2021

BUY
$30.92 - $44.4 $11.3 Million - $16.2 Million
365,464 Added 12.6%
3,266,508 $104 Million
Q4 2020

Feb 12, 2021

BUY
$33.66 - $40.76 $12.3 Million - $14.9 Million
366,152 Added 14.44%
2,901,044 $118 Million
Q3 2020

Nov 13, 2020

SELL
$33.07 - $38.68 $2.15 Million - $2.52 Million
-65,032 Reduced 2.5%
2,534,892 $94.6 Million
Q2 2020

Aug 14, 2020

BUY
$20.05 - $33.89 $52.1 Million - $88.1 Million
2,599,924 New
2,599,924 $84.9 Million

Others Institutions Holding GMAB

About GENMAB A/S


  • Ticker GMAB
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 658,292,992
  • Market Cap $13.4B
  • Description
  • Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...
More about GMAB
Track This Portfolio

Track Capital International Investors Portfolio

Follow Capital International Investors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital International Investors with notifications on news.